Thursday, May 16, 2024
HomeTagsMedical Oncology

Medical Oncology

NeoImmuneTech’s NT-I7 Creates a More Immunogenic Tumor Microenvironment when Associated with Pembrolizumab

NeoImmuneTech, Inc, a T cell-focused therapeutics company, presented data that suggests that NT-I7 plus pembrolizumab combination treatment enhances infiltration of PD-1+ T cells in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics